CNSP
NASDAQ
$5.50
Cns Pharmaceuticals Inc (CNSP)
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central nervous system tumors. The company is headquartered in Houston, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Target: $10 (+81.82%)
Market Cap
$4.14M
Price Chart
Valuation
Market Cap$4.14M
P/B106.55
Profitability
EBITDA-$17M
EPS-$25.81
Growth & Risk
FCF 5Y CAGR+11.65%
Sharpe Ratio0.35